Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1484917Generated: October 31, 2026

HCID 58169323, compound → HCID 58169323, compound

https://huagongshe.com/reaction/1484917

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHCID 58169323HCID 58169323—
ReactantHCID 58169431HCID 58169431—
ProductHCID 58169323HCID 58169323—
ProductHCID 58169431HCID 58169431—
ProductHCID 58169468HCID 58169468—

Reaction Steps

(S)-1-(5-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)-5-fluoropyrimidin-2-yl)thiophen-2yl)ethanol (Compound 144) (80 mg) and (R)-1-(5-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)-5-fluoropyrimidin-2-yl)thiophen-2-yl)ethanol (Compound 147) (75 mg) were obtained by Prep-Chiral-HPLC from the above racemic 1-(5-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)-5-fluoropyrimidin-2-yl)thiophen-2-yl)ethanol (350 mg). The stereostructure of and (R)-1-(5-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)-5-fluoropyrimidin-2-yl)thiophen-2-yl)ethanol (Compound 147) was confirmed by the comparable sample prepared from 1-(5-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)-5-fluoropyrimidin-2-yl)thiophen-2-yl)ethanone with BH3/S-CBS-Me. Synthetic procedures described as following:

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09422271B2
Source datasetuspto-grants-2016_08
ORD IDord-41c815e98cbe4ef49ce3d83057ce3615
Source noteuspto-grants-2016_08